[ad_1] Shares of Hims & Hers Health closed down around 26% on Friday after the U.S.…
Continue ReadingTag: Novo Nordisk A/S
Hims & Hers faces lawmaker scrutiny over ‘misleading’ Super Bowl ad
[ad_1] Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss…
Continue Reading
Stocks making the biggest moves midday: TXN, GRND, TWLO
[ad_1] Check out the companies making headlines in midday trading: Verizon Communications — The telecommunications giant…
Continue Reading
GLP-1s, Brian Thomson killing loom large at JPM Health
[ad_1] Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International…
Continue Reading
Stocks making the biggest moves midday: NVO, QRVO, JBHT
[ad_1] Check out the companies making headlines in midday trading. Crypto stocks – Stocks tied to…
Continue Reading
FDA Zepbound shortage ends, impacts patients, compounding pharmacies
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Continue Reading
Stocks, economic data, business news
[ad_1] European stocks closed higher on Friday, as regional markets reopened following a closure for the…
Continue Reading
stocks, news, data and earnings
[ad_1] The entrance of the London Stock Exchange Group building on Dec. 8, 2024. Manuel Romano…
Continue Reading
Digital health stocks pummeled by Wall Street in 2024, but Hims surges
[ad_1] Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE…
Continue Reading
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
[ad_1] An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…
Continue Reading